Welcome to our dedicated page for Enova Intl SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enova International, Inc. (NYSE: ENVA) files a range of documents with the U.S. Securities and Exchange Commission that provide detail on its online financial services operations, funding structures and corporate actions. On this page, you can review Enova’s SEC filings alongside AI-powered summaries that help explain key terms and highlight important points for investors.
Current reports on Form 8-K describe material events such as asset-backed securitization transactions backed by small business loans originated or purchased by OnDeck, amendments to revolving receivables facilities, new share repurchase authorizations and proposed mergers. For example, Enova has filed 8-Ks outlining an Agreement and Plan of Merger with Grasshopper Bancorp, Inc. and a subsequent amendment to that agreement, as well as filings describing securitization facilities and credit agreement amendments that support its lending activities.
Enova’s filings also address management and governance matters. An amended Form 8-K details planned leadership transitions, including changes in the roles of the company’s Chief Executive Officer, Executive Chairman and Chief Financial Officer, along with associated compensation and equity award arrangements under its long-term incentive plan. Other filings furnish earnings press releases and supplemental data related to loan performance and non-GAAP financial measures such as adjusted earnings and adjusted EBITDA.
Through this SEC filings page, users can access Enova’s quarterly reports on Form 10-Q and annual reports on Form 10-K (when available), as well as Forms 8-K and related exhibits. Real-time updates from EDGAR are combined with AI-generated explanations that clarify complex topics like securitization structures, portfolio performance covenants, revolving credit facilities and merger terms, helping readers interpret how these disclosures relate to Enova’s consumer and small business lending operations.
Enova International (ENVA) Form 144 notice: An officer or insider proposes to sell 35,000 shares of common stock through Merrill Lynch on the NYSE with an aggregate market value listed as $4,270,000. The shares were acquired on 02/12/2019 via a stock option from Enova International. The filing also discloses prior sales by the same person, totaling 57,000 shares sold across six transactions between 06/20/2025 and 09/04/2025, with reported gross proceeds for those sales. The filer represents they are not aware of undisclosed material adverse information and notes Rule 144 representations regarding trading plans.
Enova International, Inc. (ENVA) director Linda Johnson Rice purchased 1,700 shares of Enova common stock on 09/10/2025 at a reported price of $115.9471 per share. After this purchase she beneficially owned 6,257 shares.
The Form 4 was filed as a single reporting person filing and is signed by an attorney in fact, Sean Rahilly, dated 09/12/2025. The filing reports a straightforward open-market purchase by an insider; no derivative transactions or amendments are included.
David Fisher, Chief Executive Officer and a director of Enova International, Inc. (ENVA), reported transactions dated 09/04/2025. He acquired 20,000 shares through exercise of non-qualified stock options/SARs at an exercise price of $23.96 (reported as a non-derivative acquisition at $23.96) and concurrently sold 20,000 shares in multiple trades at a weighted-average sale price of $121.956 (actual trade prices ranged from $120.67 to $123.40). Following these transactions his beneficial ownership is reported as 348,223 shares. The option/SAR package vests in three equal installments (vesting completed by 02/12/2022) and the SAR has special exercise conditions tied to a change-in-control or qualifying offer. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/08/2025.
Enova International (ENVA) Form 144 shows a proposed sale of 20,000 common shares through Merrill Lynch (NYSE) with an aggregate market value of $2,420,000. The filer acquired the shares as stock options on 02/12/2019. The issuer's outstanding common shares are listed as 25,012,613. The filing also discloses sales by the same person totaling 37,000 shares in the past three months for gross proceeds of $4,405,547.79 across transactions dated 06/20/2025–08/29/2025. The filer attests there is no undisclosed material adverse information about the issuer.
Enova International insider transactions by CEO/Director David Fisher: The filing shows Mr. Fisher exercised employee stock options and simultaneously sold portions of his shares on August 28-29, 2025. He exercised a total of 25,000 options at an exercise price of $23.96 per share (15,000 on 08/28/2025 and 10,000 on 08/29/2025), increasing beneficial ownership represented by the exercised shares before sales to 363,223 and then 358,223 shares as sales occurred. On the same dates he sold 25,000 shares (15,000 and 10,000) at weighted-average prices of $121.8028 and $121.7989 respectively (execution ranges disclosed in the filing). Post-transactions his direct beneficial ownership is reported as 348,223 shares. The exercised options are non-qualified options with corresponding limited SARs that vest in prior years and expire February 12, 2026. The filing was signed by an attorney-in-fact on September 2, 2025.
Sean Rahilly, General Counsel and Secretary of Enova International, Inc. (ENVA), reported a sale of 2,965 shares of common stock on 08/28/2025 at a reported price of $122.635 per share. Following the transaction, Rahilly beneficially owns 100,877 shares. The Form 4 was signed on 09/02/2025 and contains no derivative transactions or additional explanatory text.
Enova International, Inc. amended its secured asset-backed revolving credit facility on August 28, 2025 by entering into a Third Amendment with Bank of Montreal and other lenders. The amendment increases the total commitment from $665,000,000 to $825,000,000, giving the company a larger borrowing capacity. It also extends the facility’s maturity date from June 30, 2026 to August 28, 2029, providing a longer-term funding source. In addition, the interest margin is reduced from the base rate plus 0.75% to the base rate plus 0.50% and from the SOFR rate plus 3.50% to the SOFR rate plus 3.25%, lowering borrowing costs. The agreement keeps the existing financial and other covenants, including limits on additional debt and leverage ratios.
Enova International, Inc. (ENVA) Form 144 shows a proposed sale of 10,000 common shares through Merrill Lynch (Chicago) with an aggregate market value of $1,210,000.00 and an approximate sale date of 08/29/2025 on the NYSE. The securities were acquired on 02/12/2019 by stock option from Enova International. Recent reported sales by the same account (David Fisher) in the past three months total 32,000 shares with gross proceeds of $3,090,958.57 across four transactions dated 06/20/2025, 07/14/2025, 08/26/2025 and 08/28/2025. Certain filer and issuer contact fields in the filing appear blank or not provided in the extract.
Form 144 notice for Enova International, Inc. (ENVA) reports a proposed sale of 2,965 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $363,612.78. The shares represent part of the issuer's outstanding common stock of 25,012,613 shares and are scheduled for sale on 08/28/2025 on the NYSE. The shares were acquired as restricted stock from the issuer on 02/23/2019 and payment was recorded as Not Applicable. The filer states there were no securities sold in the past three months for the account to be sold. Certain filer identification fields (CIK/CCC and submission contact details) are not provided in the document.
Enova International insider transaction by CEO David Fisher: The filing shows Mr. Fisher, who is both Chief Executive Officer and a director, completed offsetting transactions on 08/26/2025. He acquired 5,000 shares via exercise at an exercise price of $23.96, bringing his beneficial ownership to 353,223 shares. On the same date he sold 5,000 shares under a Rule 10b5-1 plan at a weighted average price of $117.8003, reducing post-transaction shares to 348,223. The sale executed in multiple trades at prices between $114.27 and $118.57. The filing also discloses the structure and vesting of related options and limited SARs and notes the option vesting schedule in 2020–2022.